Advances in the production of human monoclonal antibodies

References

• Olsson L, Kaplan HS. Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc Natl AcadSci USA. 1980;77(9):5429–5431.
   PubMed Web of Science ®Google Scholar
• MacDonald G, Primrose S, Biggins K, et al. Production and characterization of human-human and human-mouse hybridomas secreting Rh(D)-specific monoclonal antibodies. Scand J Immunol. 1987;25(5):477–483.
   Web of Science ®Google Scholar
• Ainai A, Kawase T, Ida A, et al. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells. Hum Antibodies. 2006;15(4):139–154.
   Google Scholar
• Gram H, Strittmatter U, Lorenz M, Gluck D, Zenke G. Phage display as a rapid gene expression system: production of bioactive cytokine- phage and generation of neutralizing monoclonal antibodies. J Immunol Methods. 1993;161(2):169–176.
   Web of Science ®Google Scholar
• Zhao XL, Yin J, Chen WQ, Jiang M, Yang G, Yang ZH. Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology. Microbiol Immunol. 2008;52(2):89–93.
   Web of Science ®Google Scholar
• Jakobovits A. Production of fully human antibodies by transgenic mice. Curr Opin Biotechnol. 1995;6(5):561–566.
   Web of Science ®Google Scholar
• Jakobovits A, Green LL, Hardy MC, et al. Production of antigen-specific human antibodies from mice engineered with human heavy and light chain YACs. Ann NY Acad Sci. 1995;764:525–535.
   PubMed Web of Science ®Google Scholar
• Osbourn J, Jermutus L, Duncan A. Current methods for the generation of human antibodies for the treatment of autoimmune diseases. Drug Discov Today. 2003;8(18):845–851.
   PubMed Web of Science ®Google Scholar
• Babcook JS, Leslie KB, Olsen OA, Salmon RA, Schrader JW. A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities. Proc Natl Acad Sci USA. 1996;93(15):7843–7848.
   Web of Science ®Google Scholar
• Ali M, Hitomi K, Nakano H. Generation of monoclonal antibodies using simplified single-cell reverse transcription-polymerase chain reaction and cell-free protein synthesis. J Biosci Bioeng. 2006;101(3):284–286.
   Web of Science ®Google Scholar
• Smith K, Garman L, Wrammert J, et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc. 2009;4(3):372–384.
   PubMed Web of Science ®Google Scholar
• De StGroth SF, Scheidegger D. Production of monoclonal antibodies: strategy and tactics. J Immunol Methods. 1980;35(1–2):1–21.
   Web of Science ®Google Scholar
• Kennett RH. Hybridomas: a new dimension in biological analyses. In Vitro. 1981;17(12):1036–1050.
   Google Scholar
• Steinitz M, Klein G. EBV-transformation of surface IgA-positive human lymphocytes. J Immunol. 1980;125(1):194–196.
   Web of Science ®Google Scholar
• Roome AJ, Reading CL. The use of Epstein-Barr virus transformation for the production of human monoclonal antibodies. Exp Biol. 1984;43(1):35–55.
   Google Scholar
• Robinson JE, Holton D, Pacheco-Morell S, Liu J, McMurdo H. Identification of conserved and variant epitopes of human immunodeficiency virus type 1 (HIV-1) gp120 by human monoclonal antibodies produced by EBV- transformed cell lines. AIDS Res Hum Retroviruses. 1990;6(5):567–579.
   Web of Science ®Google Scholar
• Olsson L. Human monoclonal antibodies: methods of production and some aspects of their application in oncology. Med Oncol Tumor Pharmacother. 1984;1(4):235–246.
   Google Scholar
• Yamaura N, Makino M, Walsh LJ, Bruce AW, Choe BK. Production of monoclonal antibodies against prostatic acid phosphatase by in vitro immunization of human spleen cells. J Immunol Methods. 1985;84(1–2):105–116.
   Web of Science ®Google Scholar
• Cole SP, Campling BG, Atlaw T, Kozbor D, Roder JC. Human monoclonal antibodies. Mol Cell Biochem. 1984;62(2):109–120.
   Web of Science ®Google Scholar
• Nissim A, Chernajovsky Y. Historical development of monoclonal antibody therapeutics. Handb Exp Pharmacol. 2008;(181):3–18.
   PubMedGoogle Scholar
• Yu X, McGraw PA, House FS, Crowe JE Jr. An optimized electrofusion- based protocol for generating virus-specific human monoclonal antibodies. J Immunol Methods. 2008;336(2):142–151.
   Web of Science ®Google Scholar
• Hoogenboom HR. Designing and optimizing library selection strategies for generating high-affinity antibodies. Trends Biotechnol. 1997;15(2):62–70.
   Web of Science ®Google Scholar
• Hoogenboom HR, Chames P. Natural and designer binding sites made by phage display technology. Immunol Today. 2000;21(8):371–378.
   Google Scholar
• Hoogenboom HR, Henderikx P, de Haard H. Creating and engineering human antibodies for immunotherapy. Adv Drug Deliv Rev. 1998;31(1–2):5–31.
   Web of Science ®Google Scholar
• Hoogenboom HR. Overview of antibody phage-display technology and its applications. Methods Mol Biol. 2002;178:1–37.
   PubMedGoogle Scholar
• McCafferty J, Fitzgerald KJ, Earnshaw J, et al. Selection and rapid purification of murine antibody fragments that bind a transition- state analog by phage display. Appl Biochem Biotechnol. 1994;47 (2–3):157–171; discussion 171–173.
   Web of Science ®Google Scholar
• Schofield DJ, Pope AR, Clementel V, et al. Application of phage display to high throughput antibody generation and characterization. Genome Biol. 2007;8(11):R254.
   PubMed Web of Science ®Google Scholar
• Williamson RA, Persson MA, Burton DR. Expression of a human monoclonal anti-(rhesus D) Fab fragment in Escherichia coli with the use of bacteriophage lambda vectors. Biochem J. 1991;277(Pt 2):561–563.
   Google Scholar
• Marks JD, Bradbury A. Selection of human antibodies from phage display libraries. Methods Mol Biol. 2004;248:161–176.
   PubMedGoogle Scholar
• Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol. 1991;222(3):581–597.
   PubMed Web of Science ®Google Scholar
• Marks JD, Ouwehand WH, Bye JM, et al. Human antibody fragments specific for human blood group antigens from a phage display library. Biotechnology (NY). 1993;11(10):1145–1149.
   Google Scholar
• O’Connell D, Becerril B, Roy-Burman A, Daws M, Marks JD. Phage versus phagemid libraries for generation of human monoclonal antibodies. J Mol Biol. 2002;321(1):49–56.
   Web of Science ®Google Scholar
• Bradbury AR, Marks JD. Antibodies from phage antibody libraries. J Immunol Methods. 2004;290(1–2):29–49.
   PubMed Web of Science ®Google Scholar
• Nelson AL, Dhimolea E, Reichert JM. Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov. 2010;9:767–74.
   PubMed Web of Science ®Google Scholar
• Yamashita M, Katakura Y, Shirahata S. Recent advances in the generation of human monoclonal antibody. Cytotechnology. 2007;55(2–3):55–60.
   Web of Science ®Google Scholar
• Lonberg N. Human antibodies from transgenic animals. Nat Biotechnol. 2005;23(9):1117–1125.
   PubMed Web of Science ®Google Scholar
• Lonberg N. Fully human antibodies from transgenic mouse and phage display platforms. Curr Opin Immunol. 2008;20(4):450–459.
   PubMed Web of Science ®Google Scholar
• Lonberg N. Human monoclonal antibodies from transgenic mice. Handb Exp Pharmacol. 2008;(181):69–97.
   Google Scholar
• Tiller T, Meffre E, Yurasov S, T suij i M, Nussenzweig MC, Wardemann H. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J Immunol Methods. 2008;329(1–2):112–124.
   Web of Science ®Google Scholar
• Masri SA, Rast H, Hu WG, et al. Cloning and expression in E. coli of a functional Fab fragment obtained from single human lymphocyte against anthrax toxin. Mol Immunol. 2007;44(8):2101–2106.
   Web of Science ®Google Scholar
• Jiang X, Suzuki H, Hanai Y, et al. A novel strategy for generation of monoclonal antibodies from single B cells using rt-PCR technique and in vitro expression. Biotechnol Prog. 2006;22(4):979–988.
   Web of Science ®Google Scholar
• Liao HX, Levesque MC, Nagel A, et al. High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J Virol Methods. 2009;158(1–2):171–179.
   Web of Science ®Google Scholar